Agilent Technologies (A) September straddle priced into quarter results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Agilent (A) PT Raised to $147 at BofA Securities
August 22, 2024 6:21 AM EDTBofA Securities analyst Derik de Bruin raised the price target on Agilent (NYSE: A) to $147.00 (from $140.00) while maintaining a Neutral rating.
The analyst comments "We update our forecasts, driving our PO to $147 (from $140), based on 20x CY25E Adj EBITDA vs 19x previously,... More
Agilent (A) PT Raised to $135 at Evercore ISI
August 22, 2024 5:17 AM EDTEvercore ISI analyst Vijay Kumar raised the price target on Agilent (NYSE: A) to $135.00 (from $130.00) while maintaining a In Line rating.
The analyst comments "A reported total revs of $1.578M (org decline of -4.5%), which came in ~130 bps above ST. The slightly better rev performance was driven by pharma (declined -8%) coming in slightly better, China (declined - 11%) a tad better and NASD inline with expecs (revs declined QoQ as expected). Relative to EVRe, a better biopharma, Dx & Environmental performance was partly offset by Food & Chemical end mkts coming in below.... More
Agilent (A) PT Raised to $165 at Citi
August 22, 2024 4:57 AM EDTCiti analyst Patrick Donnelly raised the price target on Agilent (NYSE: A) to $165.00 (from $150.00) while maintaining a Buy rating.
The analyst comments "Agilent reported a F3Q24 organic decline of (4.4%) ahead of guidance of (6.9%)-(4.5%) with adj. EPS of $1.32 above guidance of $1.25-1.28... More

